Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Are There Risks with Using High-THC Cannabis Strains in Panic Disorder? 

Posted
Updated
ByMy Patient Advice
Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Patients with panic disorder are increasingly cautious about high-THC risks for panic disorder. While THC can provide relief for some conditions, it may worsen anxiety symptoms in sensitive individuals. Understanding high-THC risks for panic disorder helps patients make safer choices when considering cannabis-based treatments. 

Medical Cannabis UK

Evaluating THC-Related Concerns 

Considering high-THC risks for panic disorder involves assessing both psychological and physiological impacts to minimise potential complications. 

THC Anxiety Exacerbation 

One major concern is THC anxiety exacerbation, where high doses can trigger panic attacks or increase overall anxiety levels. 

Adverse Effects 

Adverse effects of high-THC strains can include rapid heart rate, dizziness, and paranoia, which may complicate symptom management for panic disorder. 

Safety Concerns 

Clinicians emphasise safety concerns by recommending low-THC or CBD-rich alternatives to reduce the likelihood of negative outcomes. 

In summary, being aware of high-THC risks for panic disorder is crucial for anyone considering THC-based treatments. Evaluating THC anxiety exacerbation, adverse effects, and safety concerns ensures patients prioritise safe and effective symptom management. 

If you’re exploring cannabis treatment options for panic disorder, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Panic Disorder. 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories